Arkolith/Insider Trading/IMUX/Form 4

Muehler Andreas

Chief Medical OfficerIMMUNIC, INC. (IMUX) · full profile →Form 4 · filed Mar 6, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2024Disposed to issuer(D)10K——0
Mar 4, 2024Disposed to issuer(D)44K——0
Mar 4, 2024Disposed to issuer(D)65K——0
Mar 4, 2024Disposed to issuer(D)10K——0
Mar 4, 2024Disposed to issuer(D)100K——0
Mar 4, 2024Disposed to issuer(D)30K——0
Mar 4, 2024Grant(A)259K——259K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-24-000321) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML